Carlsmed, Inc. Earnings Per Share (Diluted)
Carlsmed, Inc. (CARL) reported Earnings Per Share (Diluted) of -$0.39 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-05
- Carlsmed, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.39.
- Carlsmed, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.32.
- Carlsmed, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.32.
- Carlsmed, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.40.
- Carlsmed, Inc. earnings per share, diluted for fiscal 2025 was -$2.12.
- Carlsmed, Inc. earnings per share, diluted for fiscal 2024 was -$6.11.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.39 10-Q · filed 2026-08-05 | -$0.71 10-Q · filed 2026-08-05 | -$1.03 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.43 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2026-03-31 | -$0.32 10-Q · filed 2026-05-05 | -$0.65 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.04 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$1.65 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-12-31 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$0.72 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$1.37 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$2.12 10-K · filed 2026-02-25 |
| 2025-09-30 | -$0.40 10-Q · filed 2025-11-06 | -$1.19 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$2.15 10-Q · filed 2025-11-06 | -$3.02 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-06-30 | -$1.47 10-Q · filed 2026-08-05 | -$2.94 10-Q · filed 2026-08-05 | -$3.97 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$5.85 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2025-03-31 | -$1.47 10-Q · filed 2026-05-05 | -$2.48 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$4.38 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$5.92 derived: net income ÷ weighted average shares · filed 2026-08-05 |
| 2024-12-31 | -$1.14 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$3.05 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$4.60 derived: net income ÷ weighted average shares · filed 2026-02-25 | -$6.11 10-K · filed 2026-02-25 |
| 2024-09-30 | -$2.06 10-Q · filed 2025-11-06 | -$3.46 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$4.97 10-Q · filed 2025-11-06 | |
| 2024-06-30 | -$1.55 10-Q · filed 2025-08-28 | -$2.91 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |